Kisunla Donanemab 350 mg/20 mL Concentrate for Infusion - 1 Vial is a prescription donanemab concentrate for intravenous infusion in eligible adults with early symptomatic Alzheimer’s disease and confirmed amyloid pathology.

Ingredients: Each single-dose 20 mL vial contains donanemab 350 mg (17.5 mg/mL), with sodium citrate, citric acid, sucrose, polysorbate 80 and water for injection.

Directions: Dilute and administer as an intravenous infusion by trained healthcare professionals according to the specialist’s dosing schedule and required MRI monitoring.

Important safety information: Prescription specialist medicine. Eligibility, APOE ε4 status, baseline and follow-up MRI scans, anticoagulant use and symptoms suggesting ARIA require specialist assessment. Seek urgent care for sudden neurological symptoms.